Grant Detail
The grant detail shows the name of the PI, active dates of the project, the funding institute and the abstract of the grant. This abstract is what is used to create the fingerprint of the grant. If any publications referencing this grant are found in the data, they will be listed here as well.
Role of Cell Cycle in Neurodegeneration
1 March 2008 - 28 February 2013
NATIONAL INSTITUTE ON AGING
Total Funding: $ 960,623
In previous studies, we and others showed evidence for the aberrant re-expression of a series of cell cycle-related proteins in specific vulnerable neuronal populations in Alzheimer disease (AD). That a mitotic cell cycle-related mechanism may play an important role in disease pathogenesis is highlighted by the earlier occurrence of cell cycle proteins compared to abnormal tau in AD and by their appearance at the very earliest prodrominal phase of disease (i.e., mild cognitive impairment). Furthermore, that cell cycle proteins are representative of a true cell cycle, rather than being an epiphenomena of other processes, is evident from evidence showing that there is a true mitotic alteration that leads to DNA replication (i.e., S phase) in neurons in AD. These findings led us to develop a novel hypothesis that neurodegeneration in AD, like cancer, is a disease of inappropriate cell cycle control. In support of this notion, we found that the expression a powerful cell cycle inducer, MYC, drives primary neurons to re-enter the cell cycle and, moreover, that MYC-induced cell cycle re-entry leads to tau phosphorylation. Based on these in vitro findings, we have recently developed a bitransgenic mouse model that inducibly expresses MYC specifically in forebrain neurons (CaMKII-MYC). In our preliminary analysis of these CaMKII-MYC animals, we found that MYC expression in this animal model: 1) drives neurons to enter the cell cycle; 2) causes hyperphosphorylation of tau; 3) leads to accumulation of intraneuronal AB; 4) results in a "neurodegenerative" (TUNEL) Phenotype; 5) leads to gliosis; and 6) causes major cognitive deficits (Y- maze and MWM). Since the aforementioned pathological and behavioral changes are all synonymous with AD, this mouse may be a very useful model of disease pathogenesis. The goal of this proposal is to further delineate the importance of neuronal cell cycle re-entry using this CaMKII-MYC animal model (Aim 1) and examine the effects of neuronal cell cycle re-entry under A2-rich conditions by analysis of a triple transgenic Tg2576/CaMKII-MYC mice (Aim 2). At the conclusion of these studies, we hope to not only have advanced our understanding of fundamental mechanisms that control neuronal cell cycle, particularly as it applies to AD, but also suggest novel therapies that could be manipulated to either prevent initiation of degeneration or stimulate recovery of damaged neurons in neurodegenerative conditions. Alzheimer disease is the leading cause of dementia in the United States. Recent studies have implicated inappropriate cell cycle re-entry in vulnerable neurons as playing a role in the neuronal loss, pathology, and cognitive impairment that are characteristic of the disease. This proposal will help to clarify the role of cell cycle re-entry in Alzheimer disease by characterizing a novel transgenic mouse model of cell cycle re-entry and delineating the effects of cell cycle re-entry in an amyloid-rich environment.
33 Resulting Publications
-
1.
2012Wataru Kudo; Hyun-Pil Lee; Wen-Quan Zou; Xinglong Wang; George Perry; Xiongwei Zhu; Mark A Smith; Robert B Petersen; Hyoung-gon Lee
Cellular prion protein is essential for oligomeric amyloid-β-induced neuronal cell death.
Human molecular genetics 2012;21(5):1138-44. -
2.
2012Hyun-Pil Lee; Neel Pancholi; Luke Esposito; Laura A Previll; Xinglong Wang; Xiongwei Zhu; Mark A Smith; Hyoung-gon Lee
PloS one 2012;7(1):e28033. -
3.
2011Rudy J Castellani; Yashi Gupta; Baiyang Sheng; Sandra L Siedlak; Peggy Lr Harris; Jeff M Coller; George Perry; Hyoung-Gon Lee; Massimo Tabaton; Mark A Smith; et al.
Laboratory investigation; a journal of technical methods and pathology 2011;91(12):1777-86. -
4.
2011Hyun-Pil Lee; Wataru Kudo; Xiongwei Zhu; Mark A Smith; Hyoung-gon Lee
Early induction of c-Myc is associated with neuronal cell death.
Neuroscience letters 2011;505(2):124-7. -
5.
2011Vladan P Bajić; Bo Su; Hyoung-Gon Lee; Wataru Kudo; Sandra L Siedlak; Lada Zivković; Biljana Spremo-Potparević; Ninoslav Djelic; Zorana Milicevic; Avneet K Singh; et al.
Cellular & molecular biology letters 2011;16(3):359-72. -
6.
2011Jeremy G Stone; Sandra L Siedlak; Massimo Tabaton; Asao Hirano; Rudy J Castellani; Corrado Santocanale; George Perry; Mark A Smith; Xiongwei Zhu; Hyoung-gon Lee
Journal of neuropathology and experimental neurology 2011;70(7):578-87. -
7.
2011Julie A Wolfram; Anna Liner; Sandy L Richardson; Xiongwei Zhu; Mark A Smith; Brian D Hoit; Hyoung-Gon Lee
The role of E2F1 in the development of hypertrophic cardiomyopathy.
International journal of clinical and experimental pathology 2011;4(5):521-5. -
8.
2011Sónia C Correia; Renato X Santos; George Perry; Xiongwei Zhu; Paula I Moreira; Mark A Smith
Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?
Ageing research reviews 2011;10(2):264-73. -
9.
2011David J Bonda; Hyoung-Gon Lee; Antoni Camins; Mercè Pallàs; Gemma Casadesus; Mark A Smith; Xiongwei Zhu
The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations.
Lancet neurology 2011;10(3):275-9. -
10.
2011William H Hoffman; Sandra L Siedlak; Yang Wang; Rudy J Castellani; Mark A Smith
Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis.
Brain research 2011;1369():194-202. -
11.
2011Rudy J Castellani; Summer L Nugent; Alan L Morrison; Xiongwei Zhu; Hyoung-Gon Lee; Peggy L R Harris; Vladan Bajić; Hari S Sharma; Shu G Chen; Peter Oettgen; et al.
Journal of neural transmission (Vienna, Austria : 1996) 2011;118(1):23-6. -
12.
2011Calvin Moh; Jacek Z Kubiak; Vladan P Bajic; Xiongwei Zhu; Mark A Smith; Hyoung-Gon Lee
Cell cycle deregulation in the neurons of Alzheimer's disease.
Results and problems in cell differentiation 2011;53():565-76. -
13.
2011Jeremy G Stone; Gemma Casadesus; Kasia Gustaw-Rothenberg; Sandra L Siedlak; Xinglong Wang; Xiongwei Zhu; George Perry; Rudy J Castellani; Mark A Smith
Frontiers in Alzheimer's disease therapeutics.
Therapeutic advances in chronic disease 2011;2(1):9-23. -
14.
2010Gavin A Buxton; Sandra L Siedlak; George Perry; Mark A Smith
Mathematical modeling of microtubule dynamics: insights into physiology and disease.
Progress in neurobiology 2010;92(4):478-83. -
15.
2010Lada Zivković; Biljana Spremo-Potparević; Bosiljka Plecas-Solarović; Ninoslav Djelić; Gordana Ocić; Predrag Smiljković; Sandra L Siedlak; Mark A Smith; Vladan Bajić
The journals of gerontology. Series A, Biological sciences and medical sciences 2010;65(12):1269-74. -
16.
2010Rudy J Castellani; Raj K Rolston; Mark A Smith
Disease-a-month : DM 2010;56(9):484-546. -
17.
2010Calvin F Moh; Sandra L Siedlak; Massimo Tabaton; George Perry; Rudy J Castellani; Mark A Smith
Paraffin-embedded tissue (PET) blot method: application to Alzheimer disease.
Journal of neuroscience methods 2010;190(2):244-7. -
18.
2010D J Bonda; V P Bajić; B Spremo-Potparevic; G Casadesus; X Zhu; M A Smith; H-G Lee
Review: cell cycle aberrations and neurodegeneration.
Neuropathology and applied neurobiology 2010;36(2):157-63. -
19.
2010David J Bonda; Hyun-Pil Lee; Hyoung-gon Lee; Avi L Friedlich; George Perry; Xiongwei Zhu; Mark A Smith
Novel therapeutics for Alzheimer's disease: an update.
Current opinion in drug discovery & development 2010;13(2):235-46. -
20.
2010Massimo Tabaton; George Perry; Xiongwei Zhu; Hyoung-gon Lee; Gemma Casadesus; Mark A Smith
Memantine: "hypothesis testing" not "disease modifying" in Alzheimer's disease.
The American journal of pathology 2010;176(2):540-1. -
21.
2010Katarzyna Gustaw-Rothenberg; Alan Lerner; David J Bonda; Hyoung-gon Lee; Xiongwei Zhu; George Perry; Mark A Smith
Biomarkers in Alzheimer's disease: past, present and future.
Biomarkers in medicine 2010;4(1):15-26. -
22.
2010Gang Liu; Ping Men; George Perry; Mark A Smith
Nanoparticle and iron chelators as a potential novel Alzheimer therapy.
Methods in molecular biology (Clifton, N.J.) 2010;610():123-44. -
23.
2010Paula I Moreira; Lawrence M Sayre; Xiongwei Zhu; Akihiko Nunomura; Mark A Smith; George Perry
Methods in molecular biology (Clifton, N.J.) 2010;610():419-34. -
24.
2010Burkhard Poeggeler; Kumar Sambamurti; Sandra L Siedlak; George Perry; Mark A Smith; Miguel A Pappolla
A novel endogenous indole protects rodent mitochondria and extends rotifer lifespan.
PloS one 2010;5(4):e10206. -
25.
2010David J Bonda; Hyun-pil Lee; Wataru Kudo; Xiongwei Zhu; Mark A Smith; Hyoung-gon Lee
Pathological implications of cell cycle re-entry in Alzheimer disease.
Expert reviews in molecular medicine 2010;12():e19. -
26.
2009Vladan P Bajić; Biljana Spremo-Potparević; Lada Zivković; David J Bonda; Sandra L Siedlak; Gemma Casadesus; Hyoung-Gon Lee; Mark A Smith
Medical hypotheses 2009;73(6):917-20. -
27.
2009Kai-Hui Sun; Hyoung-gon Lee; Mark A Smith; Kavita Shah
Molecular biology of the cell 2009;20(21):4611-9. -
28.
2009Mike Snape; Hyoung-gon Lee; Gemma Casadesus; Mark A Smith
Cell cycle aberrations in Alzheimer's disease: a novel therapeutic opportunity.
Expert review of neurotherapeutics 2009;9(11):1579-80. -
29.
2009David J Bonda; Teresa A Evans; Corrado Santocanale; Jesús Catalá Llosá; Jose Viña; Vladan P Bajic; Rudy J Castellani; Sandra L Siedlak; George Perry; Mark A Smith; et al.
Aging 2009;1(4):382-8. -
30.
2009Hyoung-gon Lee; Gemma Casadesus; Akihiko Nunomura; Xiongwei Zhu; Rudy J Castellani; Sandy L Richardson; George Perry; Dean W Felsher; Robert B Petersen; Mark A Smith
The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse.
The American journal of pathology 2009;174(3):891-7. -
31.
2009Hyoung-Gon Lee; Gemma Casadesus; Xiongwei Zhu; Rudy J Castellani; Andrew McShea; George Perry; Robert B Petersen; Vladan Bajic; Mark A Smith
Neurochemistry international 2009;54(2):84-8. -
32.
2009Hyoung-gon Lee; Qun Chen; Julie A Wolfram; Sandy L Richardson; Anna Liner; Sandra L Siedlak; Xiongwei Zhu; Nicholas P Ziats; Hisashi Fujioka; Dean W Felsher; et al.
PloS one 2009;4(9):e7172. -
33.
2008Biljana Spremo-Potparević; Lada Zivković; Ninoslav Djelić; Bosiljka Plećas-Solarović; Mark A Smith; Vladan Bajić
Premature centromere division of the X chromosome in neurons in Alzheimer's disease.
Journal of neurochemistry 2008;106(5):2218-23.
Scientific Context
This section shows information that has been computed by using the fingerprint of the grant, including related publications, related experts and related grants - all with fingerprints representing significant amounts of overlap between their fingerprint and this grant. The red dots indicate whether those experts or terms actually appear within this grant, showing potential and actual connections.
Related Grants
-
1.
Smith, Mark A
Cell Cycle Inhibitors in Alzheimer Disease
30 September 2007 - 31 August 2009
NATIONAL INSTITUTE ON AGING
Total Funding: $ 357,204
-
2.
DAVIES, PETER P
A Mouse Model of Tau Pathology in AD &Other Dementias
1 May 2003 - 31 March 2013
NATIONAL INSTITUTE ON AGING
Total Funding: $ 3,632,767
-
3.
MASLIAH, ELIEZER
Mechanisms of Neuroprotection in HIV Encephalitis
1 December 2000 - 31 March 2017
NATIONAL INSTITUTE OF MENTAL HEALTH
Total Funding: $ 4,089,059
Related Publications
-
1.
2009David J Bonda; Teresa A Evans; Corrado Santocanale; Jesús Catalá Llosá; Jose Viña; Vladan P Bajic; Rudy J Castellani; Sandra L Siedlak; George Perry; Mark A Smith; et al.
Aging 2009;1(4):382-8. -
2.
2005Uwe Ueberham; Thomas Arendt
The expression of cell cycle proteins in neurons and its relevance for Alzheimer's disease.
Current drug targets. CNS and neurological disorders 2005;4(3):293-306. -
3.
2006Jeroen J M Hoozemans; Jens Stieler; Elise S van Haastert; Robert Veerhuis; Annemieke J M Rozemuller; Frank Baas; Piet Eikelenboom; Thomas Arendt; Wiep Scheper
Experimental gerontology 2006;41(4):380-6.
Related Topics
Appears in this Publication
Related Experts
Author of this Publication
-
Internal ExpertsPublications
-
540









-
252









-
610









-
219









-
849









-
230











